These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

839 related items for PubMed ID: 16229851

  • 1. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M, Karry R, Aviram M.
    Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
    Kalogerakis G, Baker AM, Christov S, Rowley KG, Dwyer K, Winterbourn C, Best JD, Jenkins AJ.
    Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities.
    Rock W, Rosenblat M, Miller-Lotan R, Levy AP, Elias M, Aviram M.
    J Agric Food Chem; 2008 Sep 24; 56(18):8704-13. PubMed ID: 18759451
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies.
    Rosenblat M, Volkova N, Aviram M.
    Biofactors; 2014 Sep 24; 40(5):536-45. PubMed ID: 25230879
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.
    Cherki M, Berrougui H, Isabelle M, Cloutier M, Koumbadinga GA, Khalil A.
    Exp Gerontol; 2007 Aug 24; 42(8):815-24. PubMed ID: 17532162
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HDL--associated paraoxonase 1 (PON1) and dietary antioxidants attenuate lipoprotein oxidation, macrophage foam cells formation and atherosclerosis development.
    Aviram M.
    Pathophysiol Haemost Thromb; 2006 Aug 24; 35(1-2):146-51. PubMed ID: 16855361
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oxidative status and serum PON1 activity in beta-thalassemia minor.
    Selek S, Aslan M, Horoz M, Gur M, Erel O.
    Clin Biochem; 2007 Mar 24; 40(5-6):287-91. PubMed ID: 17296173
    [Abstract] [Full Text] [Related]

  • 18. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
    Brites FD, Verona J, Schreier LE, Fruchart JC, Castro GR, Wikinski RL.
    Arch Med Res; 2004 Mar 24; 35(3):235-40. PubMed ID: 15163466
    [Abstract] [Full Text] [Related]

  • 19. Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: comparison between humans and rats.
    Trudel K, Sinnett D, James RW, Delvin E, Amre D, Seidman E, Levy E.
    J Cell Biochem; 2005 Oct 01; 96(2):404-11. PubMed ID: 16052486
    [Abstract] [Full Text] [Related]

  • 20. Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis - a protective role for HDL phospholipids.
    Efrat M, Aviram M.
    Adv Exp Med Biol; 2010 Oct 01; 660():153-66. PubMed ID: 20221878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.